Saturday, October 10, 2020, 8:45 AM - Sunday, October 11, 2020, 11:30 AM, Online, New York, NY


As a comprehensive medical education conference, this symposium will offer the latest updates for diagnostic and treatment strategies that assess the risk and treatment of coronary artery disease, congestive heart failure, hypertension, LA appendage closure, mitral valve regurgitation, aortic stenosis, and co-morbid cardiometabolic diseases. The use of case-based reviews and taped case presentations will demonstrate innovative therapeutic techniques aimed at improving patient outcomes and quality of life, as well as lowering morbidity and mortality rates through the management of various conditions.

1. Comprehend the COVID-19 disease process and outcomes.
2. Learn to assess various CAD risk factors and imaging to provide diagnostic and prognostic information and appropriate treatment.
3. Acknowledge, through evidence-based results, recent transcatheter valve therapies with special focus on mitral and triscupid valve procedures.
4. Recognize the issues pertaining to various antithrombotics posts DES.
5. Incorporate the lastest advances within interventional cardiology and their implications in overall patient care, improving interventional outcomes.

- All Attendees: Complimentary
- CME Certificate: $25

For security purposes, credit card payment cannot be accepted by mail or fax. Please register online to pay by credit card.


The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Verification of Attendance
Verification of attendance will be provided to all professionals.

AMA PRA Category 1 Credits™ (5.50 hours), Non-Physician Attendance (5.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

If you have any questions or would like to exhibit, please contact Kimberley Kostiw at Kimberley.kostiw@mountsinai.org or 212-241-0592.

The exhibitor registration form for this activity Is currently unavailable.